Physician profile
Rolla T Nuoman
NPI 1457770620
$722.01
in general payments reported to CMS, 2019-2025
21 companies · $18.81 in 2025
The $18.81 reported for 2025 was less than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.04 · 2020: $118 · 2021: $15.50 · 2022: $202 · 2023: $201 · 2024: $72.37 · 2025: $18.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $292.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $203.60 | 2022-2024 | Qelbree, Qelbree |
| Novartis Pharmaceuticals Corporation | $68.11 | 2019-2020 | |
| Tris Pharma INC | $61.09 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $36.55 | 2022-2023 | Jornay Pm |
| Harmony Biosciences LLC | $35.57 | 2020 | |
| Ucb, INC. | $31.13 | 2022-2023 | Briviact |
| Takeda Pharmaceuticals U.S.A., INC. | $28.00 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $26.79 | 2024 | Rexulti |
| Neurelis, INC. | $25.59 | 2024 | Valtoco |
| Csl Behring | $22.51 | 2019 | |
| Jazz Pharmaceuticals INC. | $19.75 | 2022 | |
| Biomarin Pharmaceutical INC. | $19.49 | 2022 | |
| Collegium Pharmaceutical, INC. | $18.81 | 2025 | Jornay Pm |
| Biohaven Pharmaceutical Holding Company LTD. | $18.33 | 2022 | |
| Sunovion Pharmaceuticals INC. | $18.18 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $18.01 | 2022 | |
| Neos Therapeutics, LP | $17.88 | 2020 | |
| Upsher-Smith Laboratories LLC | $14.81 | 2022 | |
| Sumitomo Pharma America, INC. | $13.44 | 2023 | Aptiom |
| Greenwich Biosciences, INC. | $12.52 | 2020 | |
| Adlon Therapeutics L.P. | $11.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rolla Nuoman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.